TrueBlue (TBI)
(Delayed Data from NYSE)
$10.87 USD
-0.07 (-0.64%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $10.86 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for TrueBlue, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,906 | 2,254 | 2,174 | 1,846 | 2,369 |
Cost Of Goods | 1,400 | 1,652 | 1,613 | 1,406 | 1,743 |
Gross Profit | 506 | 602 | 560 | 441 | 626 |
Selling & Adminstrative & Depr. & Amort Expenses | 530 | 530 | 492 | 616 | 560 |
Income After Depreciation & Amortization | -24 | 72 | 68 | -175 | 66 |
Non-Operating Income | 3 | 1 | 5 | 2 | 7 |
Interest Expense | 0 | 0 | 0 | 0 | 3 |
Pretax Income | -21 | 73 | 74 | -173 | 70 |
Income Taxes | -6 | 11 | 12 | -31 | 7 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | 62 | 62 | -142 | 63 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | 62 | 62 | -142 | 63 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 11 | 101 | 96 | 32 | 104 |
Depreciation & Amortization (Cash Flow) | 35 | 29 | 28 | 207 | 38 |
Income After Depreciation & Amortization | -24 | 72 | 68 | -175 | 66 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 31.32 | 33.45 | 35.43 | 35.37 | 39.18 |
Diluted EPS Before Non-Recurring Items | 0.28 | 2.43 | 2.00 | 0.43 | 2.05 |
Diluted Net EPS (GAAP) | -0.45 | 1.86 | 1.74 | -4.01 | 1.61 |
Fiscal Year end for TrueBlue, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 492.17 | 473.20 | 475.59 | 465.29 |
Cost Of Goods | NA | 363.89 | 349.02 | 345.10 | 342.18 |
Gross Profit | NA | 128.28 | 124.17 | 130.49 | 123.11 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 136.91 | 126.90 | 137.05 | 129.06 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -8.63 | -2.73 | -6.56 | -5.95 |
Non-Operating Income | NA | 1.22 | 0.39 | 0.58 | 1.01 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -7.40 | -2.34 | -5.98 | -4.93 |
Income Taxes | NA | -4.85 | -2.33 | 1.35 | -0.64 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.55 | -0.01 | -7.32 | -4.29 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.55 | -0.01 | -7.32 | -4.29 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 31.08 | 30.93 | 30.97 | 32.29 |
Diluted EPS Before Non-Recurring Items | NA | 0.08 | 0.16 | 0.17 | -0.06 |
Diluted Net EPS (GAAP) | NA | -0.08 | 0.00 | -0.24 | -0.13 |